APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glucagon

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Selected research

Market Outlook & Growth Opportunities

Global Glucagon Market Outlook and Growth Opportunities 2026

21 December 2025199 pages

Choose your research edition.

Industry ResearchGlucagon Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Glucagon Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Glucagon Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glucagon Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Glucagon Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.

Global Glucagon main players are Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, etc. Global top four manufacturers hold a share over 80%. North America is the largest market, with a share nearly 40%.

This report provides an overview of the global Glucagon market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Glucagon and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glucagon sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glucagon market size, projected growth trends, production technologies, key applications, and end-use industries.

Glucagon Segment by Company

Novo Nordisk

Eli Lilly

Fresenius Kabi

Torrent Labs

Taj Pharmaceuticals

Xeris Pharmaceuticals

Glucagon Segment by Type

Inject Glucagon

Nasal Glucagon

Glucagon Segment by Application

Emergency Kits

General Use

Diagnostic & Motility

Cardiogenic Shock

Others

Glucagon Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Glucagon status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Glucagon market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Glucagon significant trends, drivers, influence factors in global and regions.

6. To analyze Glucagon competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glucagon market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glucagon and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glucagon.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glucagon market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Glucagon industry.

Chapter 3: Detailed analysis of Glucagon manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Glucagon in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Glucagon in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Glucagon Industry Trends Table 2. Glucagon Industry Drivers Table 3. Glucagon Industry Opportunities and Challenges Table 4. Glucagon Industry Restraints Table 5. Global Glucagon Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Glucagon Revenue Share by Company (2021-2026) Table 7. Global Glucagon Sales Volume by Company (K MT) & (2021-2026) Table 8. Global Glucagon Sales Volume Share by Company (2021-2026) Table 9. Global Glucagon Average Price (USD/MT) of Company (2021-2026) Table 10. Global Glucagon Company Ranking, (2024-2026) & (USD Million) Table 11. Global Glucagon Key Company Manufacturing Base & Headquarters Table 12. Global Glucagon Company, Product Type & Application Table 13. Global Glucagon Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Glucagon by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Inject Glucagon Table 18. Significant Companies of Nasal Glucagon Table 19. Global Glucagon Sales Volume by Type 2021 VS 2025 VS 2032 (K MT) Table 20. Global Glucagon Sales Volume by Type (2021-2026) & (K MT) Table 21. Global Glucagon Sales Volume by Type (2027-2032) & (K MT) Table 22. Global Glucagon Sales Volume Share by Type (2021-2026) Table 23. Global Glucagon Sales Volume Share by Type (2027-2032) Table 24. Global Glucagon Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Glucagon Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Glucagon Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Glucagon Sales Value Share by Type (2021-2026) Table 28. Global Glucagon Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Emergency Kits Table 30. Significant Companies of General Use Table 31. Significant Companies of Diagnostic & Motility Table 32. Significant Companies of Cardiogenic Shock Table 33. Significant Companies of Others Table 34. Global Glucagon Sales Volume by Application 2021 VS 2025 VS 2032 (K MT) Table 35. Global Glucagon Sales Volume by Application (2021-2026) & (K MT) Table 36. Global Glucagon Sales Volume by Application (2027-2032) & (K MT) Table 37. Global Glucagon Sales Volume Share by Application (2021-2026) Table 38. Global Glucagon Sales Volume Share by Application (2027-2032) Table 39. Global Glucagon Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Glucagon Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Glucagon Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Glucagon Sales Value Share by Application (2021-2026) Table 43. Global Glucagon Sales Value Share by Application (2027-2032) Table 44. Global Glucagon Sales by Region: 2021 VS 2025 VS 2032 (K MT) Table 45. Global Glucagon Sales by Region (2021-2026) & (K MT) Table 46. Global Glucagon Sales Market Share by Region (2021-2026) Table 47. Global Glucagon Sales by Region (2027-2032) & (K MT) Table 48. Global Glucagon Sales Market Share by Region (2027-2032) Table 49. Global Glucagon Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Glucagon Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Glucagon Sales Value Share by Region (2021-2026) Table 52. Global Glucagon Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Glucagon Sales Value Share by Region (2027-2032) Table 54. Global Glucagon Market Average Price (USD/MT) by Region (2021-2026) Table 55. Global Glucagon Market Average Price (USD/MT) by Region (2027-2032) Table 56. Global Glucagon Sales by Country: 2021 VS 2025 VS 2032 (K MT) Table 57. Global Glucagon Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Glucagon Sales by Country (2021-2026) & (K MT) Table 59. Global Glucagon Sales Market Share by Country (2021-2026) Table 60. Global Glucagon Sales by Country (2027-2032) & (K MT) Table 61. Global Glucagon Sales Market Share by Country (2027-2032) Table 62. Global Glucagon Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Glucagon Sales Value Market Share by Country (2021-2026) Table 64. Global Glucagon Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Glucagon Sales Value Market Share by Country (2027-2032) Table 66. Novo Nordisk Company Information Table 67. Novo Nordisk Business Overview Table 68. Novo Nordisk Glucagon Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 69. Novo Nordisk Glucagon Product Portfolio Table 70. Novo Nordisk Recent Development Table 71. Eli Lilly Company Information Table 72. Eli Lilly Business Overview Table 73. Eli Lilly Glucagon Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 74. Eli Lilly Glucagon Product Portfolio Table 75. Eli Lilly Recent Development Table 76. Fresenius Kabi Company Information Table 77. Fresenius Kabi Business Overview Table 78. Fresenius Kabi Glucagon Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 79. Fresenius Kabi Glucagon Product Portfolio Table 80. Fresenius Kabi Recent Development Table 81. Torrent Labs Company Information Table 82. Torrent Labs Business Overview Table 83. Torrent Labs Glucagon Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 84. Torrent Labs Glucagon Product Portfolio Table 85. Torrent Labs Recent Development Table 86. Taj Pharmaceuticals Company Information Table 87. Taj Pharmaceuticals Business Overview Table 88. Taj Pharmaceuticals Glucagon Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 89. Taj Pharmaceuticals Glucagon Product Portfolio Table 90. Taj Pharmaceuticals Recent Development Table 91. Xeris Pharmaceuticals Company Information Table 92. Xeris Pharmaceuticals Business Overview Table 93. Xeris Pharmaceuticals Glucagon Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 94. Xeris Pharmaceuticals Glucagon Product Portfolio Table 95. Xeris Pharmaceuticals Recent Development Table 96. Key Raw Materials Table 97. Raw Materials Key Suppliers Table 98. Glucagon Distributors List Table 99. Glucagon Customers List Table 100. Research Programs/Design for This Report Table 101. Authors List of This Report Table 102. Secondary Sources Table 103. Primary Sources List of Figures Figure 1. Glucagon Product Image Figure 2. Global Glucagon Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glucagon Sales Value (2021-2032) & (US$ Million) Figure 4. Global Glucagon Sales (2021-2032) & (K MT) Figure 5. Global Glucagon Sales Average Price (USD/MT) & (2021-2032) Figure 6. Global Glucagon Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Inject Glucagon Image Figure 10. Nasal Glucagon Image Figure 11. Global Glucagon Sales Volume by Type (2021 VS 2025 VS 2032) & (K MT) Figure 12. Global Glucagon Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Glucagon Sales Volume Share by Type (2021-2032) Figure 14. Global Glucagon Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Glucagon Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Glucagon Sales Value Share by Type (2021-2032) Figure 17. Emergency Kits Image Figure 18. General Use Image Figure 19. Diagnostic & Motility Image Figure 20. Cardiogenic Shock Image Figure 21. Others Image Figure 22. Global Glucagon Sales Volume by Application (2021 VS 2025 VS 2032) & (K MT) Figure 23. Global Glucagon Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Glucagon Sales Volume Share by Application (2021-2032) Figure 25. Global Glucagon Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Glucagon Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Glucagon Sales Value Share by Application (2021-2032) Figure 28. Global Glucagon Sales by Region: 2021 VS 2025 VS 2032 (K MT) Figure 29. Global Glucagon Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Glucagon Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Glucagon Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Glucagon Sales Value (2021-2032) & (US$ Million) Figure 33. North America Glucagon Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Glucagon Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Glucagon Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Glucagon Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Glucagon Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Glucagon Sales Value (2021-2032) & (US$ Million) Figure 39. South America Glucagon Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Glucagon Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Glucagon Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Glucagon Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Glucagon Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Glucagon Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Glucagon Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Glucagon Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Inject Glucagon
  • Nasal Glucagon
Applications
  • Emergency Kits
  • General Use
  • Diagnostic & Motility
  • Cardiogenic Shock
  • Others
Companies covered
  • Novo Nordisk
  • Eli Lilly
  • Fresenius Kabi
  • Torrent Labs
  • Taj Pharmaceuticals
  • Xeris Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glucagon Sales Value (2021-2032)
  4. 1.2.2 Global Glucagon Sales Volume (2021-2032)
  5. 1.2.3 Global Glucagon Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Glucagon Market Dynamics
  1. 2.1 Glucagon Industry Trends
  2. 2.2 Glucagon Industry Drivers
  3. 2.3 Glucagon Industry Opportunities and Challenges
  4. 2.4 Glucagon Industry Restraints
3 Glucagon Market by Company
  1. 3.1 Global Glucagon Company Revenue Ranking in 2025
  2. 3.2 Global Glucagon Revenue by Company (2021-2026)
  3. 3.3 Global Glucagon Sales Volume by Company (2021-2026)
  4. 3.4 Global Glucagon Average Price by Company (2021-2026)
  5. 3.5 Global Glucagon Company Ranking (2024-2026)
  6. 3.6 Global Glucagon Company Manufacturing Base and Headquarters
  7. 3.7 Global Glucagon Company Product Type and Application
  8. 3.8 Global Glucagon Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Glucagon Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Glucagon Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Glucagon Market by Type
  1. 4.1 Glucagon Type Introduction
  2. 4.1.1 Inject Glucagon
  3. 4.1.2 Nasal Glucagon
  4. 4.2 Global Glucagon Sales Volume by Type
  5. 4.2.1 Global Glucagon Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Glucagon Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Glucagon Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Glucagon Sales Value by Type
  9. 4.3.1 Global Glucagon Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Glucagon Sales Value by Type (2021-2032)
  11. 4.3.3 Global Glucagon Sales Value Share by Type (2021-2032)
5 Glucagon Market by Application
  1. 5.1 Glucagon Application Introduction
  2. 5.1.1 Emergency Kits
  3. 5.1.2 General Use
  4. 5.1.3 Diagnostic & Motility
  5. 5.1.4 Cardiogenic Shock
  6. 5.1.5 Others
  7. 5.2 Global Glucagon Sales Volume by Application
  8. 5.2.1 Global Glucagon Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Glucagon Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Glucagon Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Glucagon Sales Value by Application
  12. 5.3.1 Global Glucagon Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Glucagon Sales Value by Application (2021-2032)
  14. 5.3.3 Global Glucagon Sales Value Share by Application (2021-2032)
6 Glucagon Regional Sales and Value Analysis
  1. 6.1 Global Glucagon Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glucagon Sales by Region (2021-2032)
  3. 6.2.1 Global Glucagon Sales by Region: 2021-2026
  4. 6.2.2 Global Glucagon Sales by Region (2027-2032)
  5. 6.3 Global Glucagon Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Glucagon Sales Value by Region (2021-2032)
  7. 6.4.1 Global Glucagon Sales Value by Region: 2021-2026
  8. 6.4.2 Global Glucagon Sales Value by Region (2027-2032)
  9. 6.5 Global Glucagon Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Glucagon Sales Value (2021-2032)
  12. 6.6.2 North America Glucagon Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Glucagon Sales Value (2021-2032)
  15. 6.7.2 Europe Glucagon Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Glucagon Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Glucagon Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Glucagon Sales Value (2021-2032)
  21. 6.9.2 South America Glucagon Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Glucagon Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Glucagon Sales Value Share by Country, 2025 VS 2032
7 Glucagon Country-level Sales and Value Analysis
  1. 7.1 Global Glucagon Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Glucagon Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Glucagon Sales by Country (2021-2032)
  4. 7.3.1 Global Glucagon Sales by Country (2021-2026)
  5. 7.3.2 Global Glucagon Sales by Country (2027-2032)
  6. 7.4 Global Glucagon Sales Value by Country (2021-2032)
  7. 7.4.1 Global Glucagon Sales Value by Country (2021-2026)
  8. 7.4.2 Global Glucagon Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Glucagon Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Glucagon Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Glucagon Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Glucagon Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Glucagon Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Glucagon Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Glucagon Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Glucagon Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Glucagon Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Glucagon Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Glucagon Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Glucagon Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Glucagon Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Glucagon Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Glucagon Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Glucagon Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Glucagon Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Glucagon Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Glucagon Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Glucagon Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Glucagon Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Glucagon Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Glucagon Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Glucagon Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Glucagon Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Glucagon Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Glucagon Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Glucagon Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Glucagon Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Glucagon Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Glucagon Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Glucagon Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Glucagon Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Glucagon Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Glucagon Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Glucagon Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Glucagon Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Glucagon Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Glucagon Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Glucagon Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Glucagon Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Glucagon Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Glucagon Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Glucagon Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Glucagon Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Glucagon Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Glucagon Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Glucagon Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Glucagon Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Glucagon Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Glucagon Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Glucagon Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Glucagon Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Glucagon Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Glucagon Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Glucagon Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Glucagon Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Glucagon Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Glucagon Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Glucagon Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Glucagon Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Glucagon Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Glucagon Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Glucagon Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Glucagon Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Glucagon Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Glucagon Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Glucagon Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Glucagon Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Glucagon Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Glucagon Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Glucagon Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Glucagon Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Glucagon Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Glucagon Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Glucagon Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Glucagon Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Glucagon Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Glucagon Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Glucagon Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Glucagon Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Glucagon Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Glucagon Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Glucagon Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novo Nordisk
  2. 8.1.1 Novo Nordisk Company Information
  3. 8.1.2 Novo Nordisk Business Overview
  4. 8.1.3 Novo Nordisk Glucagon Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novo Nordisk Glucagon Product Portfolio
  6. 8.1.5 Novo Nordisk Recent Developments
  7. 8.2 Eli Lilly
  8. 8.2.1 Eli Lilly Company Information
  9. 8.2.2 Eli Lilly Business Overview
  10. 8.2.3 Eli Lilly Glucagon Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly Glucagon Product Portfolio
  12. 8.2.5 Eli Lilly Recent Developments
  13. 8.3 Fresenius Kabi
  14. 8.3.1 Fresenius Kabi Company Information
  15. 8.3.2 Fresenius Kabi Business Overview
  16. 8.3.3 Fresenius Kabi Glucagon Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Kabi Glucagon Product Portfolio
  18. 8.3.5 Fresenius Kabi Recent Developments
  19. 8.4 Torrent Labs
  20. 8.4.1 Torrent Labs Company Information
  21. 8.4.2 Torrent Labs Business Overview
  22. 8.4.3 Torrent Labs Glucagon Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Torrent Labs Glucagon Product Portfolio
  24. 8.4.5 Torrent Labs Recent Developments
  25. 8.5 Taj Pharmaceuticals
  26. 8.5.1 Taj Pharmaceuticals Company Information
  27. 8.5.2 Taj Pharmaceuticals Business Overview
  28. 8.5.3 Taj Pharmaceuticals Glucagon Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Taj Pharmaceuticals Glucagon Product Portfolio
  30. 8.5.5 Taj Pharmaceuticals Recent Developments
  31. 8.6 Xeris Pharmaceuticals
  32. 8.6.1 Xeris Pharmaceuticals Company Information
  33. 8.6.2 Xeris Pharmaceuticals Business Overview
  34. 8.6.3 Xeris Pharmaceuticals Glucagon Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Xeris Pharmaceuticals Glucagon Product Portfolio
  36. 8.6.5 Xeris Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glucagon Value Chain Analysis
  2. 9.1.1 Glucagon Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glucagon Sales Mode & Process
  6. 9.2 Glucagon Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glucagon Distributors
  9. 9.2.3 Glucagon Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst